BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20693556)

  • 21. Hydroxychloroquine-Induced Retinal Toxicity.
    Iselin KC; Marti P; Pless M
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):514-6. PubMed ID: 27116524
    [No Abstract]   [Full Text] [Related]  

  • 22. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 23. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG.
    Marmor MF
    Am J Ophthalmol; 2005 Nov; 140(5):894-5. PubMed ID: 16310466
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxychloroquine screening.
    Lee AG
    Br J Ophthalmol; 2005 May; 89(5):521-2. PubMed ID: 15834072
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA; Maker MP; Marmor MF
    JAMA Ophthalmol; 2019 Jan; 137(1):109-110. PubMed ID: 30452517
    [No Abstract]   [Full Text] [Related]  

  • 30. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fluorangiographic data on hydroxychloroquine retinopathy in patients with rheumatoid arthritis].
    Trotta F; Sebastiani A; Piccinini P
    Reumatismo; 1972; 24(4):265-73. PubMed ID: 4681349
    [No Abstract]   [Full Text] [Related]  

  • 33. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C; Bechetoille A; Ebran JM
    J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.
    Marmor MF
    Arthritis Rheum; 2003 Jun; 48(6):1764. PubMed ID: 12794848
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK; Robinson M; Mandal N; Shah VA
    Indian J Ophthalmol; 2015 Jul; 63(7):570-4. PubMed ID: 26458473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
    Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
    Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity.
    Anderson C; Pahk P; Blaha GR; Spindel GP; Alster Y; Rafaeli O; Marx JL
    Retina; 2009 Sep; 29(8):1188-92. PubMed ID: 19491724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB; Marmor MF
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.